Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Egyptian Pharmaceutical Journal [National Research Center]. 2007; 6 (2): 103-116
Dans Anglais | IMEMR | ID: emr-82451

Résumé

The present work was carried out to study the effect of phoxim and amitraz insecticides on fetal development and newborns in rats. Oral administration of phoxim in doses of 110 and 220 mg kg[-1] b.wt. to pregnant rats during the period of organogenesis significantly increased the number of resorbed fetuses and decreased the number, body weight and length of viable ones. Dilatation of cerebral ventricles, pulmonary hypoplasia and dilatation of renal pelvis were reported as visceral malformations. Skeletal examination of fetuses revealed incomplete ossification of skull bones and aplasia of pelvic girdle bones and sternebrae. Large dose of phoxim caused aplasia of some vertebrae, metacarpals, metatarsals and digits. Pregnant rats were given amitraz orally in doses of 40 and 80 mg kg[-1] b.wt. during the period of organogenesis had resorbed, dead and growth retarded viable fetuses. Anencephaly and dilatation of cerebral ventricles and renal pelvis were observed in the examined fetuses. Skeletal abnormalities of viable fetuses were incomplete ossification of skull bones and aplasia of sternebrae. Large dose of amitraz induced aplasia of some vertebrae, metacarpals, metatarsals and digits. Oral administration of phoxim in doses of 110 and 220 mg kg[-1] b,wt. to pregnant rats from the 15[th] day of gestation till the end of weaning period [the 21[st] day post-parturition] caused a significant decrease in the weight of delivered offsprings. Death of all newborns occurred in the 21[st] and the 14[th] day post-parturition by the small and large doses respectively. Oral administration of amitraz in doses of 40 and 80 mg kg[-1] b.wt. to pregnant rats for the same period significantly decreased the number of delivered offsprings. Death of all newborns occurred in the 14[th] and 4[th] day post-parturition by the small and large dose respectively


Sujets)
Animaux de laboratoire , Développement foetal , Animaux nouveau-nés , Gestation animale , Rats , Tératogènes , Composés organothiophosphorés/effets indésirables , Toluidines/effets indésirables
2.
Veterinary Medical Journal. 1996; 44 (2): 471-477
Dans Anglais | IMEMR | ID: emr-43642

Résumé

The disposition kinetics and milk and urine concentration of apramycin were estimated in six goats. Following intramuscular and intravenous injection of 20 mg/kg b. wt., blood milk and urine samples were collected at 5, 15, 30 minutes, 1, 2, 4, 6, 8, 10, 12 hours post injected. The collected samples were used for determination of apramycin concentration using the microbiological assay method. Following intramuscular injection of apramycin, the highest concentration in serum was recorded at 1 hour with t0.5 [ab] value f 47.78 minutes and t0.5 [beta] f 1.53 hours. The peak milk and urine concentration was reached at 4 hours. Following intravenous injection of apramycin it follows two-compartment model with t0.5 [alpha] 14.11 minutes and t0.5 [beta] 3.22 hours, vc 0.97 l/kg. The C1[B] was 1.668 ml/kg. The mean systemic bioavailability was 78.25%. The protein binding% of apramycin of serum and milk was 8.5% and 39.25%, respectively


Sujets)
Capra
SÉLECTION CITATIONS
Détails de la recherche